Skip to main content
Premium Trial:

Request an Annual Quote

Farewell to Francis, and Scientists Break Down Personalized Medicine

Charlie Rose has a series of interviews, one with Navigenics' David Agus, Dean Ornish, and George Church, and another with Francis Collins. In the first, they talk about personalized medicine, personal genomics, and what people should understand and be aware of. "Initially, people should keep their expectations low," says Church, but Agus, who went on Lipitor as a prophylactic against his 80 percent increased risk of having a heart attack, thinks that "this is a very important way of understanding the genetics of disease." In another interview, Rose chats with Francis Collins about what's next for him -- he officially leaves his post at NHGRI today -- and for genetic research.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.